Literature DB >> 23942404

Meningitis due to Neisseria meningitidis serogroup B in India.

Meenakshi Aggarwal1, Vikas Manchanda, B Talukdar.   

Abstract

Invasive meningococcal disease has a fulminant course and high mortality. Neisseria meningitidis serogroup A is predominantly responsible for meningococcal disease in India and the developing countries. Group B meningococcus, which is prevalent in the developing world is uncommon in India. We herein report the second case of group B meningococcal infection from the country, two decades after the reporting of the first case. Ineffective vaccines against serogroup B warrant the need for close surveillance of this disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23942404

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  3 in total

Review 1.  Meningococcal Disease Burden in India: A Systematic Review and Meta-Analysis.

Authors:  Canna Jagdish Ghia; Gautam Sudhakar Rambhad
Journal:  Microbiol Insights       Date:  2021-11-29

2.  Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India.

Authors:  Anand P Dubey; Rashna Dass Hazarika; Veronique Abitbol; Shafi Kolhapure; Someya Agrawal
Journal:  Hum Vaccin Immunother       Date:  2022-03-03       Impact factor: 3.452

Review 3.  Meningococcal Disease and Immunization Activities in Hajj and Umrah Pilgrimage: a review.

Authors:  Selim Badur; Mansour Khalaf; Serdar Öztürk; Rajaa Al-Raddadi; Ashraf Amir; Fayssal Farahat; Atef Shibl
Journal:  Infect Dis Ther       Date:  2022-05-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.